The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system
Authors:
- Irene Díaz-AlberolaIrene Díaz-Alberola
- Daniel E. Di Zeo-SánchezDZDaniel E. Di Zeo-Sánchez
- Vanesa Garrido-RodríguezVGVanesa Garrido-Rodríguez
- Carlos López-GómezCLCarlos López-Gómez
- Cristina Rodríguez-DíazCRCristina Rodríguez-Díaz
- Raul J. AndradeRARaul J. Andrade
- M. Isabel LucenaM. Isabel Lucena
- Marina Villanueva-PazMarina Villanueva-Paz
- Eduardo García-FuentesEGEduardo García-Fuentes
Open Access
- 24 April 2026
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (7) , 4233-4260
Abstract
No abstract availableKeywords
Funding Information
- Agencia Estatal de Investigación (PID2022-140169OB-C21)
- Innovative Medicines Initiative (101095679)
- Innovative Medicines Initiative (HORIZON-HLTH2022-STAYHLTH-02)
- Innovative Medicines Initiative (821283)
- Consejería de Salud y Consumo, Junta de Andalucía (RC-0005-2020)
- Consejería de Salud y Consumo, Junta de Andalucía (CP23/00088)
- Consejería de Salud y Consumo, Junta de Andalucía (RHJ-0052-2024)
- Universidad de Málaga (PPRO-CTS1032-G-2023)
- Universidad de Málaga (PPRO-CTS649-G-2023)
- European Commission
- Instituto de Salud Carlos III (IFI21/00034)
- Instituto de Salud Carlos III (CP22/00050)
- Ministerio de Ciencia, Innovación y Universidades
- HORIZON EUROPE Framework Programme
- Innovative Health Initiative
- European Regional Development Fund (FORT23/00013)
This publication has 327 references indexed in Scilit:
- Lymphocyte Profile and Immune Checkpoint Expression in Drug‐Induced Liver Injury: An Immunophenotyping StudyClinical Pharmacology & Therapeutics, 2021
- Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in miceEuropean Journal of Immunology, 2020
- Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cellsEuropean Journal of Immunology, 2018
- Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium PerspectiveClinical Pharmacology & Therapeutics, 2018
- Toll‐like receptor 5 signaling restrains T‐cell/natural killer T‐cell activation and protects against concanavalin A–induced hepatic injuryHepatology, 2017
- Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcomeHepatology, 2014
- Immune tolerance in liver diseaseHepatology, 2014
- Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical AssociationsHepatology, 2014
- Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and FibrosisHepatology, 2013
- High-mobility group box 1 (HMGB1)-toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophagesHepatology, 2012